BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 25, 2012
View Archived Issues
Novel cytochrome P450 inhibitors patented by German university
Read More
Research in Korea yields new HIF1-alpha inhibitors
Read More
Ardelyx describes novel phosphate transport inhibitors
Read More
Pfizer describes novel antiandrogen for castration-resistant prostate cancer
Read More
High-risk prostate carcinoma-related death linked to miR-221 expression
Read More
Bionomics commences phase I/II trial of vasculature-disrupting agent in ovarian cancer
Read More
Genmab receives Arzerra milestone payment
Read More
In vivo results presented for new antibody-drug conjugate
Read More
Novel treatments for Parkinson's disease prepared at Merck & Co.
Read More
Scientists at Nektar Therapeutics present new polymer-GLP-1 conjugates
Read More
Morphotek produces novel monoclonal antibodies for cancer
Read More
Merck & Co. describes novel protein kinase inhibitors
Read More
Rigel presents preclinical data for new antiasthma drug candidate
Read More
Anti-IL10 receptor monoclonal antibody enhances BCG antitumor responses
Read More
XenoPort submits IND for potential multiple sclerosis treatment
Read More
Second cohort opens enrollment in ATOMIC-AHF trial
Read More
Lucigen receives NIH grant for RNA-based diagnostic
Read More
Kancera's ROR inhibitors show activity against fludarabine-resistant CLL
Read More
Oryzon set to begin preclinical development of hematological cancer drug
Read More
Chugai files for approval in Japan of pertuzumab
Read More
PharmaGap conditionally approves offer for GAP-107B8 license
Read More
IMI launches public-private research program to combat antibiotic resistance
Read More
Shionogi obtains additional approvals for carbapenem-type antibiotic in Japan
Read More
FDA advisory committee votes on Pfizer's data package for TTR stabilizer
Read More
RetroSense Therapeutics obtains guidance for lead biologic for eye diseases
Read More
AstraZeneca obtains approval for Inderal for new indication in Japan
Read More